Study Details

Back
Study ID 8232-CL-3001
Study Title A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects with Diabetic Macular Edema
Clinicaltrials.gov Identifier NCT02302079
Compound Name ASP8232
Medical Indication or Disease Diabetic macular edema
Study Sponsor Astellas Pharma B.V.
Collaborator Not Applicable
Study Start Date 12-Jan-2015
Study Completion Date 12-Aug-2016
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS